Pulsetech

Company profile

Pulsetech company profile

Pulsetech is a pre-clinical neurotechnology company developing next-generation neuromodulation solutions aimed at halting the progression of neurological disorders, with an initial focus on Parkinson’s disease and sleep-related neurodegeneration. The company is building a sleep-aware, closed-loop DBS platform that integrates real-time brain signal sensing with adaptive stimulation algorithms to address pathological neural activity during critical sleep stages. By intervening during sleep, a period strongly linked to disease progression, Pulsetech aims to shift neuromodulation from symptomatic control toward disease-modifying impact. Pulsetech has raised $1 million and has initiated pre-clinical trials, advancing toward proof-of-concept studies. The company is supported by a multidisciplinary team and a growing Scientific Advisory Board comprising leading experts in neuromodulation, sleep neuroscience, and neurodegenerative disease.